Grufity logo
Grufity logo
CLBS

CLBS - Caladrius Biosciences Inc Stock Price, Fair Value and News

$108.500.00 (0.00%)
Market Closed as of 31 Jul 2026, 04:00 pm ET

3/100

CLBS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

3/100

CLBS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

CLBS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CLBS Price Action

Last 30 days

34.8%

Last 90 days

26.9%

Trailing 12 Months

-36.2%

CLBS RSI Chart

CLBS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CLBS Valuation

Market Cap

988.0M

Price/Earnings (Trailing)

-60.43

Price/Sales (Trailing)

3.4K

EV/EBITDA

-58.46

Price/Free Cashflow

-72.49

CLBS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

CLBS Fundamentals

CLBS Revenue

Revenue (TTM)

290.0K

Rev. Growth (Yr)

-54.89%

Rev. Growth (Qtr)

20%

CLBS Earnings

Earnings (TTM)

-16.4M

Earnings Growth (Yr)

4.97%

Earnings Growth (Qtr)

-51.96%

CLBS Profitability

Operating Margin

-7457.37%

EBT Margin

-5771.72%

Return on Equity

-149.65%

Return on Assets

-116.3%

Free Cashflow Yield

-1.38%

CLBS Investor Care

Shares Dilution (1Y)

5.86%

Diluted EPS (TTM)

-1.86

Revenue & Growth

How Caladrius Biosciences Inc generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2026290.0K---
2025859.0K718.0K577.0K436.0K
20242.6M2.5M2.2M1.0M
20231.7M2.2M2.6M2.7M
2022191.0K238.0K534.0K1.1M
2021120.5K109.0K125.0K151.0K
2020-23.9M12.0M132.0K
201735.7M---
201626.8M29.2M32.7M35.3M
201518.2M18.4M20.2M22.5M
2014-15.8M16.8M17.9M
2013-14.4M14.6M14.7M
201212.4M13.5M15.8M14.3M
2011---28.2M
2010----
2009---11.6M
2008----
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Caladrius Biosciences Inc

CLBS
0
 WEBSITEcaladrius.com

Caladrius Biosciences Inc Frequently Asked Questions

CLBS is the stock ticker symbol of Caladrius Biosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jul 31 2026, market cap of Caladrius Biosciences Inc is 988.04 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Jul 31 2026, CLBS's PE ratio (Price to Earnings) is -60.43 and Price to Sales (PS) ratio is 3.41 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CLBS PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Caladrius Biosciences Inc has provided 0.545 (multiply by 100 for percentage) rate of return.